159 related articles for article (PubMed ID: 37051865)
1. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis.
Jensen S; Bloch Z; Quist M; Hansen TTD; Johansen C; Pappot H; Suetta C; Skjødt Rafn B
Acta Oncol; 2023 Mar; 62(3):318-328. PubMed ID: 37051865
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
[TBL] [Abstract][Full Text] [Related]
3. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer.
Stene GB; Helbostad JL; Amundsen T; Sørhaug S; Hjelde H; Kaasa S; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):340-8. PubMed ID: 25225010
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Skeletal Muscle Mass Change During Chemotherapy: A Systematic Review and Meta-analysis.
Jang MK; Park C; Hong S; Li H; Rhee E; Doorenbos AZ
Anticancer Res; 2020 May; 40(5):2409-2418. PubMed ID: 32366384
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis.
Buentzel J; Heinz J; Bleckmann A; Bauer C; Röver C; Bohnenberger H; Saha S; Hinterthaner M; Baraki H; Kutschka I; Emmert A
Anticancer Res; 2019 Sep; 39(9):4603-4612. PubMed ID: 31519557
[TBL] [Abstract][Full Text] [Related]
8. The Effectiveness of Sarcopenia Interventions for Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-analysis.
Jang MK; Park C; Tussing-Humphreys L; Fernhall B; Phillips S; Doorenbos AZ
Cancer Nurs; 2023 Mar-Apr 01; 46(2):E81-E90. PubMed ID: 34054070
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A).
Sasaki S; Oki E; Saeki H; Shimose T; Sakamoto S; Hu Q; Kudo K; Tsuda Y; Nakashima Y; Ando K; Akagi Y; Kakeji Y; Baba H; Maehara Y
Int J Clin Oncol; 2019 Oct; 24(10):1204-1213. PubMed ID: 31062115
[TBL] [Abstract][Full Text] [Related]
10. Development of Sarcopenia in Patients With Bladder Cancer: A Systematic Review.
Hansen TTD; Omland LH; von Heymann A; Johansen C; Clausen MB; Suetta C; Pappot H; Rafn BS
Semin Oncol Nurs; 2021 Feb; 37(1):151108. PubMed ID: 33431235
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
12. Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes.
Catikkas NM; Bahat Z; Oren MM; Bahat G
Aging Clin Exp Res; 2022 Aug; 34(8):1747-1759. PubMed ID: 35169986
[TBL] [Abstract][Full Text] [Related]
13. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
14. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis.
Hein TR; Peterson L; Bartikoski BJ; Portes J; Espírito Santo RC; Xavier RM
Arthritis Res Ther; 2022 Jul; 24(1):171. PubMed ID: 35854372
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis.
Jogiat UM; Bédard ELR; Sasewich H; Turner SR; Eurich DT; Filafilo H; Baracos V
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2630-2636. PubMed ID: 36151845
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer.
Lee J; Kim EY; Kim E; Kim KG; Kim YJ; Kim YS; Ahn HK; Lee SW
Thorac Cancer; 2021 Jun; 12(11):1662-1667. PubMed ID: 33829665
[TBL] [Abstract][Full Text] [Related]
17. The effect of Tai Chi in elderly individuals with sarcopenia and frailty: A systematic review and meta-analysis of randomized controlled trials.
Huang CY; Mayer PK; Wu MY; Liu DH; Wu PC; Yen HR
Ageing Res Rev; 2022 Dec; 82():101747. PubMed ID: 36223875
[TBL] [Abstract][Full Text] [Related]
18. The assessment and impact of sarcopenia in lung cancer: a systematic literature review.
Collins J; Noble S; Chester J; Coles B; Byrne A
BMJ Open; 2014 Jan; 4(1):e003697. PubMed ID: 24384894
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis.
Jang MK; Park S; Raszewski R; Park CG; Doorenbos AZ; Kim S
Support Care Cancer; 2024 May; 32(5):328. PubMed ID: 38702479
[TBL] [Abstract][Full Text] [Related]
20. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.
Takenaka Y; Oya R; Takemoto N; Inohara H
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1122-1135. PubMed ID: 34337889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
